641 related articles for article (PubMed ID: 15464749)
1. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
Zhuang ZP; Kung MP; Wilson A; Lee CW; Plössl K; Hou C; Holtzman DM; Kung HF
J Med Chem; 2003 Jan; 46(2):237-43. PubMed ID: 12519062
[TBL] [Abstract][Full Text] [Related]
3. Amyloid imaging: from benchtop to bedside.
Wu C; Pike VW; Wang Y
Curr Top Dev Biol; 2005; 70():171-213. PubMed ID: 16338342
[TBL] [Abstract][Full Text] [Related]
4. Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.
Ono M; Kawashima H; Nonaka A; Kawai T; Haratake M; Mori H; Kung MP; Kung HF; Saji H; Nakayama M
J Med Chem; 2006 May; 49(9):2725-30. PubMed ID: 16640332
[TBL] [Abstract][Full Text] [Related]
5. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
6. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
7. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
8. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M
Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062
[TBL] [Abstract][Full Text] [Related]
9. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
10. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
11. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
12. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.
Mathis CA; Wang Y; Holt DP; Huang GF; Debnath ML; Klunk WE
J Med Chem; 2003 Jun; 46(13):2740-54. PubMed ID: 12801237
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
[TBL] [Abstract][Full Text] [Related]
15. [Introduction to and general remarks on molecular imaging].
Fukuda H; Okamura N
Brain Nerve; 2007 Mar; 59(3):203-7. PubMed ID: 17370645
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
17. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
Ono M; Haratake M; Mori H; Nakayama M
Bioorg Med Chem; 2007 Nov; 15(21):6802-9. PubMed ID: 17826102
[TBL] [Abstract][Full Text] [Related]
18. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains.
Ono M; Cheng Y; Kimura H; Cui M; Kagawa S; Nishii R; Saji H
J Med Chem; 2011 Apr; 54(8):2971-9. PubMed ID: 21428407
[TBL] [Abstract][Full Text] [Related]
19. Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients.
Gulyás B; Spenger C; Beliczai Z; Gulya K; Kása P; Jahan M; Jia Z; Weber U; Pfeifer A; Muhs A; Willbold D; Halldin C
Neurochem Int; 2012 Jan; 60(2):153-62. PubMed ID: 22100791
[TBL] [Abstract][Full Text] [Related]
20. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
